Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
As previously disclosed in a Current Report on Form 8-K filed with the
Securities and Exchange Commission (the "SEC") on December 10, 2021, Blonder
Tongue Laboratories, Inc. (the "Company") received written notification from
NYSE American LLC ("NYSE American" or the "Exchange") stating that the staff of
NYSE Regulation had determined to commence proceedings to delist the common
stock of the Company (the "Common Stock") from the Exchange. NYSE Regulation
staff has determined that the Company is no longer suitable for listing pursuant
to Section 1009(a) of the NYSE American Company Guide (the "Company Guide") as
the Company was unable to demonstrate that it had regained compliance with
Sections 1003(a)(i), (ii) and (iii) of the Company Guide by the end of the
maximum 18-month compliance plan period, which expired on December 10, 2021.
The Company appealed such determination, and a hearing was scheduled to take
place on June 28, 2022 . On June 24, 2022, after the Company's Board of
Directors determined the Company will not be able to regain compliance with the
above referenced listing standards in the short term, the Company cancelled the
appeal hearing and requested its Common Stock be withdrawn from being listed on
the Exchange. As a result, we expect the trading of the Common Stock on the
Exchange to be terminated on June 24, 2022.
The Company expects the Common Stock to commence trading under the symbol "BDRL"
on the OTCQB marketplace operated by OTC Markets Group Inc. The Company expects
the Common Stock to commence trading on the OTCQB on June 27, 2022.
Item 8.01 Other Events.
On June 24, 2022, the Company issued a press release announcing the cancellation
of the hearing and the withdrawal of the Common Stock from the Exchange. A copy
of the press release is provided as Exhibit 99.1 to this Current Report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number Description
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).© Edgar Online, source Glimpses
BLONDER TONGUE LABORATORIES, INC. 
